Zydus Cadila gets USFDA gesture to showcase its disease treatment infusion Kumar Jeetendra | September 11, 2020 New Delhi, Sep 11 (PTI) Medication firm Zydus Cadila on Friday said it has received final nod in the US health regulator to advertise its generic Doxorubicin Hydrochloride Liposome injection, used for treatment of certain types of cancer, in the American market. The company has received final approval from the United States Food and Drug …
